click for details →
Betagan (U.S.N.L.M.)
| ||
|---|---|---|
| Dosing | 0.5%: 1 or 2 drops qd to start, bid max. 0.25%: 1 or 2 drops bid. | |
| Chem Specs | levobunolol HCL 0.25%, 0.5% | |
| Quantities | 5, 10, 15ml (0.5%) 10, 15ml (0.25%) | |
| Cost | 4.00/5ml 0.5% generic (Target AKBeta) | |
| Class | Beta 1 selective Beta-Blocker | |
| Action | Ocular hypotensive via decrease in aqueous humor production. | |
| Usage | Indicated for lowering IOP with chronic open-angle glaucoma or ocular hypertension. | |
| Evaluate blood pressure, pulse, neurological and respiratory status before and during treatment. |
||
| Contraindications | Asthma, COPD, bradycardia and/or congestive heart failure, uncontrolled diabetes and hyperlipidemia. |
|
| Pediatric use | Safety and effectiveness in pediatric patients have not been established. | |
| Pregnancy | Category C | |
| Longest half-life of the topical beta-blockers. Dosages above 1 drop 0.5% bid are generally not more effective. Studies support 1 drop 0.25% qd for some. BAK preserved. |
||